DAPSONE

Clinical Indication

Dermatology

Comments

See shared care agreement for details.

Date of classification

April 2024

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.